2,9-Di(cyclohexyl)-anthra2,1,9-def:6,5,10-defdiisoquinoline-1,3,8,10-tetrone

Catalog No. :
ACKDJR346
CAS No. :
41572-86-5
Molecular Formula :
C36H30N2O4
Molecular Weight :
554.65

IUPAC Name:2,9-dicyclohexylanthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetraone

2,9-Di(cyclohexyl)-anthra2,1,9-def:6,5,10-defdiisoquinoline-1,3,8,10-tetrone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,9-Di(cyclohexyl)-anthra2,1,9-def:6,5,10-defdiisoquinoline-1,3,8,10-tetrone
IUPAC Name2,9-dicyclohexylanthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetraone
MDL No.MFCD00799276
Molecular FormulaC36H30N2O4
Molecular Weight554.65
SMILESO=C1N(C(C2=CC=C3C4=CC=C5C(N(C(C6=CC=C(C7=CC=C1C2=C37)C4=C65)=O)C8CCCCC8)=O)=O)C9CCCCC9
InChI KeyCHMHJESZTNVQSO-UHFFFAOYSA-N
SynonymN,N' -Dicyclohexylperylene-3,4:9,10-tetracarboxylic acid bisimide;DCyPTC;Anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetrone, 2,9-dicyclohexyl-;S1083;2,9-dicyclohexylanthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetraone;N,N'-Dicyclohexylperylene-3,4:9,10-tetracarboxylic acid bisimide;2,9-Di(cyclohexyl)-anthra2,1,9-def:6,5,10-d'e'f'diisoquinoline-1,3,8,10-tetrone
CAS No.41572-86-5
PubChem CID10506951

Synthetic Route by SureRoute

1. ACKDJR346 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKDJR346 route product structure diagram
    ACKDJR34641572-86-5
Inquiry

2. ACKDJR346 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKDJR346 route product structure diagram
    ACKDJR34641572-86-5
Inquiry

Comments (0)